Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial

Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial

Abstract Background Dose reduction of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukaemia (CML) with an optimal response to TKIs may support cost-effective medication use by maintaining therapeutic effectiveness while reducing adverse events and medication costs. As the choic...

Full description

Bibliographic Details
Main Authors: Melissa F Djodikromo, Rosella PMG Hermens, Bart JF van den Bemt, Yolba Smit, Tim M Govers, Charlotte L Bekker, Nicole MA Blijlevens
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Cancer
Subjects:
Chronic myeloid leukaemia
Tyrosine kinase inhibitors
Dose reduction
Shared decision making
Patient-centred care
Online Access:https://doi.org/10.1186/s12885-023-10697-6

Internet

https://doi.org/10.1186/s12885-023-10697-6

Similar Items